Sonendo (SONX) versus The Competition Critical Survey

Sonendo (NYSE:SONX) is one of 13 publicly-traded companies in the “Dental equipment & supplies” industry, but how does it compare to its rivals? We will compare Sonendo to related businesses based on the strength of its valuation, analyst recommendations, institutional ownership, earnings, profitability, dividends and risk.

Profitability

This table compares Sonendo and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sonendo	-138.88%	-121.92%	-58.04%
Sonendo Competitors	-38.28%	-17.92%	-8.74%

Earnings and Valuation

This table compares Sonendo and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sonendo	$43.87 million	-$60.92 million	-0.14
Sonendo Competitors	$1.59 billion	-$43.82 million	0.89

Sonendo’s rivals have higher revenue and earnings than Sonendo. Sonendo is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Sonendo has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500. Comparatively, Sonendo’s rivals have a beta of 1.15, indicating that their average stock price is 15% more volatile than the S&P 500.

Institutional & Insider Ownership

28.7% of Sonendo shares are owned by institutional investors. Comparatively, 44.9% of shares of all “Dental equipment & supplies” companies are owned by institutional investors. 6.4% of Sonendo shares are owned by insiders. Comparatively, 28.3% of shares of all “Dental equipment & supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and target prices for Sonendo and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0	3	1	0	2.25
Sonendo Competitors	58	218	261	0	2.38

Sonendo presently has a consensus target price of $1.88, indicating a potential upside of 1,900.43%. As a group, “Dental equipment & supplies” companies have a potential upside of 28.43%. Given Sonendo’s higher probable upside, analysts clearly believe Sonendo is more favorable than its rivals.

Summary

Sonendo rivals beat Sonendo on 10 of the 12 factors compared.

About Sonendo

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.